International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2021   Volume 11   Issue 1

Naproxen in Pain and Inflammation – A Review
Download PDF


, , ,
Citation
Vancouver
Stoev SN, Gueоrguiev SR, Madzharov VG, Lebanova HV. Naproxen in Pain and Inflammation – A Review. Int J Pharm Phytopharmacol Res. 2021;11(1):142-8. https://doi.org/10.51847/bQYcToiEbj
APA
Stoev, S. N., Gueоrguiev, S. R., Madzharov, V. G., & Lebanova, H. V. (2021). Naproxen in Pain and Inflammation – A Review. International Journal of Pharmaceutical And Phytopharmacological Research, 11(1), 142-148. https://doi.org/10.51847/bQYcToiEbj
Download citation:   EndNote   RIS
Article Link:
Abstract

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are the main therapeutic alternatives in treating pain and inflammation among various populations. However, they are linked with some adverse reactions and drug interactions. This review aims to summarize the naproxen mechanism of action and place it in the therapeutic strategy. Naproxen is a reversible inhibitor of the pro-inflammatory enzyme cyclooxygenase (COX)  used in clinical practice for control of pain of various origin, namely post-traumatic pain (distortion and sprain), post-operative pains (in traumatology, orthopedics, gynecology, maxillofacial surgery), gynecological pains (pain and discomfort at primary dysmenorrhea, after the introduction of an intrauterine coil, etc.), headache and toothache, prevention or treatment of migraine, spinal pains, extra-articular rheumatism. It has been established that the duration of pain relief after a single dose of naproxen is significantly greater than after the intake of ibuprofen-containing products of equal concentration in the post-operative period of dental intervention. Naproxen is recommended as a drug for the choice of the class of tNSAIDs also in many national therapeutic guidelines (England, Canada, Russia).

Volume 15
Issue 1
2025

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2024 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.